|
|
||||||||
1Lovelace Respiratory Research Institute, Albuquerque, New Mexico; and 2The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
Submitted 7 December 2005 ; accepted in final form 25 May 2006
| ABSTRACT |
|---|
|
|
|---|

T cells were significantly higher in naive and allergen-challenged bim/ mice compared with wild-type (WT) littermates. When activated, pulmonary bim/ T cells produced increased levels of IFN
compared with bim+/+ T cells. No differences were noted in the total numbers of epithelial cells per millimeter of basal lamina between bim+/+ and bim/ mice, and the rate of resolution over 15 days of exposure was similar in both groups of mice. However, GCM was significantly enhanced and expression of IL-13R
2 was reduced in bim/ mice compared with WT mice at 4 days. Furthermore, treatment of bronchiolar explant cultures with increasing IFN
levels reduced immunostaining for IL-13R
2. Collectively, these studies suggest that, during prolonged exposure to allergen, Bim plays no role in the resolution of GCM, but increased IFN
levels in bim/ mice may be responsible for reduced expression of IL-13R
2 and enhanced GCM despite similar levels of IL-13 in bim+/+ and bim/ mice.
asthma; interferon-
and tolerance; apoptosis; IL-13R
2; mucous cell metaplasia
The Bcl-2 family of proteins are critical regulators of apoptotic cell death. These proteins contain variable numbers of four conserved Bcl-2 homology (BH) domains, all of which include
-helical segments (29). Anti-apoptotic members, such as Bcl-2 and Bcl-xL, contain all BH domains. The pro-apoptotic proteins are subdivided into multidomain members such as Bax and Bak (containing BH1, -2, and -3) and the BH3-only members such as Bid and Bim, which share only the BH3 region with their relatives. These so-called BH3-only proteins bind via their
-helical BH3 domain to a groove formed by the BH1, -2, and -3 domains on the surface of pro-survival Bcl-2 family members, and this interaction is required for their ability to kill cells (21). Bim, 1 of 10 mammalian BH3-only proteins, is expressed as many isoforms, which are generated by alternative splicing (28), (1) and is found in many cell types including lymphocytes, myeloid cells, epithelial cells, neurons, and germ cells (30). The pro-apoptotic activity of Bim can be regulated by a range of mechanisms such as transcriptional induction by FOXO3A (12, 44), sequestration of the protein to the microtubular dynein motor complex by interaction with dynein-like chain LC8 (32), and Erk-mediated phosphorylation leading to ubiquitination and proteasomal degradation (24). The pro-apoptotic function of Bim can also be inhibited by anti-apoptotic players, such as Bcl-2 or Bcl-xL (5). Deletion of the bim gene in mice produced animals with abnormally elevated numbers of T as well as B cells in all hemopoietic organs (3). In culture, these lymphocytes displayed abnormal resistance to certain apoptotic stimuli, including cytokine deprivation or calcium flux, but they had normal or only slightly reduced sensitivity to other death stimuli such as phorbol ester and DNA damage that could be countered by expression of a Bcl-2 transgene (3, 20). Further studies in vivo demonstrated that Bim is an essential initiator of apoptosis in negative selection of autoreactive thymocytes (4), mature T cells (7), and B cells (11) in shut down of T cell immune responses to a herpes simplex virus infection (31) or an injected superantigen (20).
We had observed that allergen-induced GCM is reduced by apoptotic mechanisms during prolonged exposures to allergen (45). Because Bim has been shown to be expressed in epithelial cells (30), the present study investigated whether Bim has a role in the cell death process of metaplastic mucous cells and other airway epithelial cells during the resolution of inflammation after prolonged exposure to allergen. While the resolution of GCM was not affected by the loss of Bim, we found that Bim enhanced allergen-induced GCM because of increased levels of IFN
that downregulated IL-13R
2 expression.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Sensitization and allergen challenge protocols. Mice, 68 wk of age, were housed in whole body exposure chambers (H1000; Hazelton Systems, Aberdeen, MD) in shoebox-type plastic cages with hardwood chip bedding and were given food and water ad libitum inside the chambers. Chamber temperatures were maintained at 26 ± 2°C, and lights were on a 12:12-h on-off cycle. Mice were sensitized by injection (ip) with 10 µg of ova albumin (OVA, grade V; Sigma-Aldrich, St. Louis, MO) adsorbed to 2 µg of Alhydrogel (Superfos Bisector) in 0.5 ml of sterile water. A booster injection was given on day 7, using the same reagents. Seven days later, mice were exposed 6 h/day to OVA aerosols. OVA exposures were generated by aerosolizing (6 h/day, 5 days/wk) 1% heat-aggregated OVA (chicken egg, grade V; Sigma), diluted with filtered air, and then delivered to whole body exposure chambers. The total mass concentration of OVA was determined by gravimetric analysis of filter samples taken every 2 h during exposure. The mass concentration of OVA was 2.3 mg/m3. Mice were exposed to allergen for 4 or 15 consecutive days and euthanized immediately after the last exposure. Naive mice that were and not sensitized served as 0 time point.
Collection of BALF and cell counting. Mice were injected (ip) with 150 units of heparin (ICN Biomedical, Aurora, OH) 10 min before euthanization with 0.2 ml of 1:10 Euthasol (penytoin sodium; Delmarva Laboratories, Midlothian, VA) and exsanguination via the renal artery. The thoracic content was exposed, and the lungs were perfused by cardiac puncture with 0.9% saline (wt/vol; McGraw, Irvine, CA). The trachea was cannulated with a 23-gauge blunt needle tipped with surgical tubing, the lungs were lavaged three times with 0.5 ml of ice-cold PBS, and the BALF was collected. The cells recovered by lavage were counted using a hemacytometer. Cytological preparations were prepared and stained with Wright Giemsa solution (Sigma-Aldrich) to determine the different types of cells present in the BALF. At least 400 cells were counted from each slide, and the distribution of macrophages, neutrophils, eosinophils, and lymphocytes was determined.
Isolation of lung cells. The lung cells were isolated using a procedure adapted from Lovchik et al. (25). Briefly, the lavaged lungs were minced and incubated with collagenase A (0.7 mg/ml; Roche Applied Science, Indianapolis, IN) in RPMI-1640 (Gibco, Grand Island, NY) with 5% FBS (Hyclone, Logan, UT) and DNase I (0.03 mg/ml; Sigma-Aldrich) for 90 min at 37°C with agitation. Digested lungs were passed through a wire mesh cup. Larger particles were removed from the digested lung by gravitational flow through a syringe column plugged with loose nylon wool. Cells in suspension were pelleted and resuspended in RPMI-1640 with 5% FBS, and red blood cells were lysed by incubating the homogenate with red blood cell lysis buffer (0.15 M NH4Cl, 1 mM KHCO3, and 0.1 mM Na2EDTA, pH to 7.4 with 1 N HCl) at room temperature for 1 min. Cells were pelleted and resuspended in RPMI-1640 with 5% FBS. Cellular debris was removed by spinning the homogenate through a 30% Percoll-PBS solution (Amersham Biosciences) and removing the supernatant. The cell pellet was resuspended in RPMI-1640 with 5% FCS, and live cells were stained with Trypan blue and counted with the use of a hemacytometer. To obtain a sufficient number of lung cells for analyses of secreted cytokines and for immunophenotyping of pulmonary T cells, isolated lung cells from three to four mice had to be pooled. We have, therefore, 1015 mice/group for cell counts and cytokine assays within the BALF but only 36/group for immunophenotyping and for analyses of secreted cytokines from isolated lung cells.
Cytokine secretion and ELISA measurements.
For cytokine secretion studies, a portion of the isolated lung cells was incubated on 100 x 20 mm tissue culture plates for 2 h at 37°C, 5% CO2, to remove adherent cells. Nonadherent cells were recovered and resuspended in lung cell medium (2 mM L-glutamine, 100 U/ml penicillin-streptomycin, 1 mM MEM-sodium pyruvate, and 1x MEM nonessential amino acids; all from Gibco) with 5 x 105 M
-mercaptoethanol (Sigma-Aldrich), 1 µg/ml indomethacin (Sigma-Aldrich), 250 U/ml catalase (Sigma-Aldrich), and 10% FCS in RPMI-1640. Cells were either left unstimulated or were stimulated with concanavalin A (5 µg/ml; Sigma-Aldrich) for 72 h at 37°C, 5% CO2. Culture supernatants were collected, frozen at 80°C, and analyzed for cytokine content at a later time.
ELISA plates (Greier Bio-Ore, USA Scientific) were coated with capture antibodies diluted in 0.1 M Na2HPO4 overnight at 4°C, washed, and blocked with 1% BSA in PBS. Samples were added to the plates after subsequent washes and incubated overnight at 4°C. Detection proceeded the following day by adding biotinylated monoclonal antibodies, streptavidin-horseradish peroxidase (1 µg/ml), and ABTS substrate, and the light absorption was read at optical density (OD)405 nm. Pairs of monoclonal antibodies against IFN
(R46A2 and biotin-XMG1.2) were purchased from BD Biosciences Pharmingen, San Diego, CA. Antibodies specific for IL-13 (38213.11 and biotin-BAF413) were purchased from R&D Systems, Minneapolis, MN. Cytokines were quantified by comparison with standard curves generated using recombinant cytokines (BD Biosciences Pharmingen). Detection limits were assigned as the lowest concentration in the linear portion of the standard curve (IFN
at 190 pg/ml, IL-13 at 20 pg/ml).
Immunophenotyping by flow cytometry.
A portion of the isolated lung cells were subjected to direct immunofluorescence staining for T-lymphocyte markers and then counted by three-colored flow cytometric analysis. All conjugated monoclonal antibodies (Ab) were purchased from BD Biosciences Pharmingen. T cells (1 x 106) from each sample were washed with 1% FCS-PBS, resuspended in 0.0125 mg/ml Mouse BD Fc Block, and allowed to incubate at 4°C for 10 min. Samples were washed and resuspended in 10 µg/ml FITC-conjugated hamster anti-mouse 
T-cell receptor Ab, 8 µg/ml R-phycoerthrin-conjugated rat anti-mouse CD8a (Ly-2) Ab, and 4 µg/ml PerCP-conjugated rat anti-mouse CD4 (L3T4) Ab solution in 1% FCS-PBS and allowed to incubate at 4°C for 30 min. Incubation with these primary antibodies was followed by three washes in 1% FCS-PBS and fixation with 0.5% paraformaldehyde (Sigma-Aldrich) at 4°C. All cells were analyzed in a Becton Dickinson FACSCalibur (BD Biosciences Pharmingen), and the data were analyzed using the BD CellQuestPro v.4.0.1 program.
Histological evaluation. Airway perfusion for whole lung fixation for histopathological examinations was performed as described previously (41). Briefly, lungs were inflated with 1x zinc formalin (3.7% zinc formalin; Anatech, Battlecreek, MI) at a hydrostatic pressure of 25 cm for 1 h and immersed in a large volume of the same fixative for 1 day.
A stratified random-sampling scheme was used to cut the fixed left lung into cross-sectional slices, each
0.4-cm thick. Tissue slices were prepared, embedded in paraffin, and sectioned at 5-µm thickness for histochemical staining. Tissue sections were stained with Alcian blue and periodic acid-Schiff (AB/PAS) or hematoxylin and eosin as described (10, 42). The number of AB-positive cells per millimeter basal lamina (BL) was quantified using an Olympus BH-2 light microscope equipped with the NIH Image analysis system (National Institutes of Health, Bethesda, MD) by counting the number of mucous cells and dividing by the length of the BL. The volume of stored mucosubstances in airway epithelia was analyzed by procedures as described (18). Briefly, the volume (in nl) of mucus per unit area (in mm2) of basement membrane (Vs) was determined from the area of AB/PAS-stained material in the epithelium using the equation Vs = (area of mucous in mm2 x 1,000)/(length of BL in mm x 1.27). Regions of epithelium lining the bronchus-associated lymphoid tissue are not representative of the epithelium in the remainder of an airway and were, therefore, excluded from all morphometric analyses. Morphometry in all sections was carried out by a person unaware of the exposure history of mice from which the airway tissues were taken.
Microdissected airway cultures.
Distal airway bronchioles were removed by microdissection and placed in culture essentially as described (50). Briefly, after removal from mice, lungs were inflated with 1% SeaPlaque low-melting temperature agarose (FMC Bioproducts, Rockland, ME) in 2x DMEM (Life Technologies, Grand Island, NY), and distal airway branches were dissected starting from the branch point. Up to 15 bronchioles were obtained from each mouse, and 3 bronchioles were used for each treatment. Bronchioles from at least three mice were prepared for each treatment to normalize for mouse-to-mouse variability. Distal airways (35/well) were transferred to 0.4-µm pore size Transwell (Costar, Pleasanton, CA) mesh inserts in 12-well plates. Four hundred milliliters of media were added to the bottom of the Transwell system and 60 µl to the top chamber with the bronchioles. Culture media, previously described (50), were changed 24 h after placing the organ cultures and every other day thereafter. Bronchioles were kept in culture at the air-liquid interface for 7 days while being treated with IL-13 at 1 ng/ml and IFN
at 0, 1, 10, or 50 ng/ml. Explants were fixed in zinc formalin for 24 h and preembedded in 1% agarose before processing for paraffin embedding. Tissue sections (5 µm) were then prepared and subjected to immunostaining procedures.
Immunohistochemistry.
Endogenous peroxidase activity was blocked by incubating sections in 2% hydrogen peroxide-methanol for 1 min. Slides were washed in deionized water, and all subsequent washes consisted of 0.05% Brij-Dulbecco's PBS (pH 7.4). Proteins were unmasked by incubation of tissue sections with a trypsin solution (Zymed, San Francisco, CA) at 37°C for 10 min as described by the manufacturer. Slides were first incubated for blocking in 1% normal goat serum in 2% BSA-0.1% Triton X-100 before the Bim (Stressgen Biotechnologies, San Diego, CA; at 1:500 dilution) or the IL-13R
2 (R&D Systems, Minneapolis, MN; at 5 µg/ml) antibodies were applied. After an overnight incubation at room temperature, the bound antibodies were visualized using biotinylated goat-anti-rabbit antibody, VECTASTAIN ABC reagent, and the peroxidase substrate diaminobenzidine (DAB; Vector Laboratories, Burlingame, CA) as described by the manufacturer. Epithelial cells with mucosubstances were detected by counter-staining tissue sections with AB (19).
Immunoblot detection of proteins.
Protein extracts were prepared from the entire right lung of mice by homogenization in radioimmunoprecipitation assay (RIPA) buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 1% Triton X-100, 1% deoxycholate, 0.1% SDS, 5 mM EDTA) supplemented with the protease inhibitors PMSF (1 mM), pepstatin (10 µg/ml), aprotinin (2 µg/ml), and benzamidine (2 µg/ml) and analyzed by Western blotting as described (46). The polyclonal rabbit anti-Bim (human, rat, mouse antibody; Stressgen) that detects the three isoforms, BimEL, BimL, and BimS, was used at 1:500 dilution. For detection of IFN
, the biotinylated rat anti-mouse IFN
(BD Biosciences Pharmingen) was used at 1:100 dilution (5 µg/ml).
Statistical analysis. Grouped results from at least four different mice were expressed as means ± SE. Data were analyzed using Statistical Analysis Software (SAS) from the SAS Institute (Cary, NC). Results grouped by time point and genotype were analyzed using two-way analysis of variance (ANOVA). When significant main effects were detected (P < 0.05), Fishers least significant difference test was used to determine differences between groups. A P value of <0.05 was considered to indicate statistical significance.
| RESULTS |
|---|
|
|
|---|
5-fold) in bim/ compared with bim+/+ littermates at 4 days as well as at 15 days of exposure. Furthermore, while the number of lymphocytes were increased from 0 to 4 days in bim/ mice, a statistically nonsignificant increase in lymphocytes was found in bim+/+ mice at 4 days that disappeared to background levels at 15 days (Fig. 1D). In bim+/+ mice, IL-13 levels significantly increased from 0 to 4 days and decreased from 4 to 15 days, whereas IL-13 levels in bim/ mice remained unchanged overall (Fig. 2A). No differences in IFN
levels were observed between bim+/+ and bim/ at any time point (Fig. 2B).
|
|

T cells in the lungs were significantly increased in naive bim/ mice compared with naive bim+/+ mice (Fig. 3). Although the numbers of CD4+8 and CD48+ cells were not different between bim/ and bim+/+ mice at 4 days of allergen exposure, their numbers were statistically different at 15 days of exposure because of an apparent decrease from 4 to 15 days in bim+/+ mice. No apparent difference was observed at 4 days between bim/ and bim+/+ mice because of a statistically nonsignificant increase in the numbers of CD4+8 and CD48+ T cells in bim+/+ mice (Fig. 3, A and B). Most strikingly, there was an approximate fivefold increase in the numbers of 
T cells in bim/ mice compared with bim+/+ mice in nonexposed and allergen-exposed mice. The number of 
T cells remained unchanged throughout the exposure period in both bim+/+ and bim/ mice (Fig. 3C).
|
compared with T cells from bim+/+ mice, although at 4 days, this difference was only marginally significant (Fig. 4B). Cells that were not treated with concanavalin A showed a similar pattern of cytokine secretion; however, the levels of IL-13 and IFN
were in the range of concentration of 0.204 ng/ml. This finding was confirmed by analyzing the protein extracts from bim+/+ and bim/ lung and finding that IFN
levels were significantly higher in bim/ compared with bim+/+ lungs (Fig. 4C). Densitometric analysis of the bands representing Bim normalized to the actin band showed twofold increased IFN
levels in bim/ compared with bim+/+ lungs (data not shown).
|
80 to
130 cells/mm BL from 0 to 4 days was followed by an apparent decrease to
100 cells/mm BL from day 4 to day 15 of allergen exposure. No significant differences were observed between bim+/+ and bim/ mice, suggesting that Bim does not play a role in the resolution of epithelial cell hyperplasia during prolonged exposure to allergen.
|
|
2 expression in bim+/+ mice inhibit the effect of IL-13. IL-13R
2 functions as an inhibitor of IL-13 signaling and Stat 6-responsive gene expression, likely by functioning as a decoy receptor (14, 34). T cells showed no immunostaining for IL-13R
2 in both bim+/+ and bim/ mice (not shown). However, while immunoreactivity to IL-13R
2 was present in airway epithelia from both bim+/+ and bim/ mice that were devoid of GCM, little to no immunostaining was observed with IL-13R
2 antibodies in bim/ mice in areas with extensive GCM (Fig. 6, I and J).
To further investigate whether increased presence of IFN
may have affected expression of IL-13R
2, we treated explant cultures of mouse bronchioles from WT mice with 1 ng/ml IL-13 combined with 0, 1, 10, or 50 ng/ml IFN
. Immunohistochemical staining showed that expression if IL-13R
2 decreased with increasing IFN
levels in the culture medium (Fig. 7, AD).
|
| DISCUSSION |
|---|
|
|
|---|
The number of neutrophils, macrophages, and eosinophils increased over 4 days of allergen exposure and then decreased to background levels from day 4 to day 15 of exposure in both bim+/+ and bim/ mice, suggesting that the death of neutrophils and eosinophils is not Bim dependent. We have previously reported that the decrease in number of eosinophils during prolonged exposure to allergen is not affected by loss of Bax (45). Others have shown that eosinophils are cleared by apoptosis through the Fas-FasL-dependent pathway (48). The death of neutrophils has been reported to be initiated by reactive oxygen species, which then activate autocrine and paracrine death receptor signaling (38). However, whereas the numbers of lymphocytes were increased
2-fold in bim+/+ mice from 0 to 4 days of exposure, their numbers increased by approximately
10-fold in bim/ mice during this time. This observation suggests that at least some T cells may undergo a Bim-dependent apoptosis in WT mice during early time points of allergen exposure. However, this increase in T cell numbers may also be due to increased numbers of precursor T cells recruited to the lung or altered T-cell proliferation in bim/ mice. Furthermore, whereas T-cell numbers in the BALF decreased from 4 to 15 days in bim+/+ mice, their numbers remained at high levels in bim/ mice, suggesting that Bim is essential for the removal of T cells during prolonged allergen exposures.
Bim can be present in at least three isoforms, BimS, BimL, and BimEL, generated by alternative splicing (28, 30). Some studies have found numerous additional isoforms, all generated by alternative splicing (1, 26, 49). However, only the BimEL form was detected in the lungs of allergen-exposed bim+/+ mice; the BimL, BimS, or other isoform was either present at below detection levels or absent. The antibody used detected all three isoforms, BimEL, BimL, and BimS, in lung extracts from rats (data not shown).
As expected, bim/ mice had increased levels of pulmonary CD4+8, CD48+, and 
T cells. This finding is in agreement with previous reports demonstrating that both the CD48 pro-T cells and the mature T cells (CD4+8 and CD48+) were two- to threefold higher in bim/ compared with bim+/+ littermates (3). Bim is required for deletion of autoreactive thymocytes (4) as well as mature CD48+ T cells (7) and of T-cell receptor/CD3-induced killing of semimature (CD4+8HSA+) thymocytes (51). In addition, Bim was shown to be required for the shut down of T-cell immune responses in vivo (20, 31).
No differences in IFN
levels were observed in the BALF of bim+/+ and bim/ mice, but T cells isolated from the lung tissues of both naive and allergen-exposed bim/ mice had a capacity to produce approximately fourfold more IFN
compared with those from bim+/+ mice. Furthermore, immunoblotting of lung extracts showed that IFN
levels are higher in bim+/+ compared with bim/ lungs. These results suggest that Bim deficiency preferentially sustains 
T cells that are known to produce IFN
, indicating that bim/ T cells are biased toward Th1 cytokine production and that most of the IFN
in the BALF may be derived from cell types other than T cells, natural killer cells being likely candidates.
The numbers of airway epithelial cells did not differ significantly between bim+/+ and bim/ mice; however, exposure to allergen did increase the numbers of total epithelial cells per millimeter BL at 4 days of allergen exposure in both sets of animals. No increase in epithelial cells was observed after a single antigen challenge in BALB/c mice (13). Reader et al. (36) reported that after three allergen challenges, each 3 days apart, 10% of mucous cells proliferated. In those studies, the increase in the numbers of mucous cells was accompanied by a compensatory decrease in Clara and ciliated cell numbers (36). The increase in total cell number observed in our study may be due to the repeated daily challenge with allergen for 6 h/day over 4 days, which may cause significant injury to the lung.
While exposure to allergen for 15 days did not completely reverse this increase, the reduction of airway epithelial cells from 4 to 15 days was similar in bim+/+ and bim/ mice, suggesting that the absence of Bim has no effect on the resolution of airway epithelial cell hyperplasia in allergen-exposed mice. A previous study reported low to moderate levels of Bim expression in ciliated epithelia of the trachea and bronchi, but no Bim was found in the alveoli of the lung (30). In this study, we were able to detect Bim in macrophages but not in airway epithelial cells (data not shown). The absence of Bim in epithelial cells is consistent with the observation that Bim deficiency had no effect on the resolution of airway epithelial cells after allergen exposure.
As previously described (41), GCM was significantly increased in WT mice at 4 days and significantly decreased from 4 to 15 days of allergen exposure. Both quantification of intraepithelial-stored mucosubstances (Vs) and the number of goblet cells per millimeter BL showed similar results, indicating that increases were due to GCM and not only enlargement of existing mucous cells. The question of whether increased number of T cells together with increased GCM in bim/ mice will result in more severe airway hyperresponsiveness could be studied in the future. Interestingly, the number of goblet cells and the total epithelial cell numbers increased by
30 in bim/ mice at 4 days of allergen challenge, suggesting that all proliferating cells differentiated into mucus-producing cells. Similarly, we have previously shown that proliferating cells differentiate into mucous cells after an intratracheal instillation of rats with LPS (47).
In general, immunoreactivity for IL-13R
2 was dramatically reduced or absent in epithelia of bim/ mice, where GCM was extensive compared with what was observed in bim+/+ mice. IL-13R
2 functions as an inhibitor of IL-13 signaling and Stat 6-responsive gene expression, likely by functioning as a decoy receptor (14, 34). Both IL-13
1 and IL-13R
2 receptors are expressed in lung epithelial cells (8, 55). However, because IL-13R
2 binds IL-13 with 50- to 100-fold higher affinity than IL-13R
1 (8), it is possible that, despite similar IL-13 levels in bim+/+ and bim/ mice, reduced expression of IL-13R
2 allows IL-13 to cause increased GCM in bim/ mice.
The abnormal increase in the numbers of mucous cells in bim/ mice at 4 days of allergen challenge may result from the presence of abnormally increased levels of IFN
, which may enhance GCM induced by the Th2 cytokine IL-13, which is the main cytokine to induce GCM in airway epithelia (23, 53, 56, 57). This hypothesis is supported by our finding that expression of IL-13R
2 was reduced in IL-13-treated organ cultures when explants were co-treated with increasing concentrations of IFN
. The reduction of IL-13R
2 expression suggests that, in bim/ mice, high IFN
levels may have downregulated expression of this decoy receptor, thereby enhancing the effect of IL-13 to induce increased GCM. Zheng et al. (55) have reported that IL-13R
2 levels are increased in both IL-13- and IFN
-overexpressing transgenic mice. However, they did not study the effect of combined treatment with IL-13 and IFN
over a long period, as our study did. We have previously reported that IFN
suppresses allergen-induced GCM (41). Such a double-sided effect of IFN
(inhibiting some, potentiating others) on IL-13-induced changes in the lungs has been reported by various groups (15, 17, 35).
The mechanism underlying the development of tolerance after prolonged exposure to allergen has been reported to be both dependent (27) and independent (39, 40) of IFN
and 
T cells. Results from our studies suggest that, while the deletion of pulmonary T cells is Bim dependent, the mechanisms involved in the death of dendritic and regulatory T cells (37) that may be responsible for inhibiting prolonged Th2 responses are probably independent of Bim.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
but not Fas mediates reduction of allergen-induced mucous cell metaplasia by inducing apoptosis. J Immunol 168: 47644771, 2002.
-induced resolution of allergen-induced mucous cell metaplasia. J Immunol 169: 59195925, 2002.This article has been cited by other articles:
![]() |
K. Schwalm, J. F. Stevens, Z. Jiang, M. R. Schuyler, R. Schrader, S. H. Randell, F. H. Y. Green, and Y. Tesfaigzi Expression of the proapoptotic protein Bax is reduced in bronchial mucous cells of asthmatic subjects Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1102 - L1109. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xiang, J. Rir-Sim-Ah, and Y. Tesfaigzi IL-9 and IL-13 Induce Mucous Cell Metaplasia That Is Reduced by IFN-{gamma} in a Bax-Mediated Pathway Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 310 - 317. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||